Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $10.93 billion. The enterprise value is $10.51 billion.
Important Dates
The last earnings date was Thursday, February 20, 2025, after market close.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 136.17 million shares outstanding. The number of shares has increased by 20.27% in one year.
| Current Share Class | 113.74M |
| Shares Outstanding | 136.17M |
| Shares Change (YoY) | +20.27% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | 16.94% |
| Owned by Institutions (%) | 80.03% |
| Float | 112.84M |
Valuation Ratios
The trailing PE ratio is 107.04 and the forward PE ratio is 23.37. Globus Medical's PEG ratio is 2.05.
| PE Ratio | 107.04 |
| Forward PE | 23.37 |
| PS Ratio | 4.32 |
| Forward PS | 4.09 |
| PB Ratio | 2.64 |
| P/TBV Ratio | 5.61 |
| P/FCF Ratio | 26.98 |
| P/OCF Ratio | 21.00 |
| PEG Ratio | 2.05 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 22.19, with an EV/FCF ratio of 25.94.
| EV / Earnings | 102.08 |
| EV / Sales | 4.17 |
| EV / EBITDA | 22.19 |
| EV / EBIT | 47.85 |
| EV / FCF | 25.94 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.54 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 1.08 |
| Debt / FCF | 1.33 |
| Interest Coverage | 52.45 |
Financial Efficiency
Return on equity (ROE) is 2.52% and return on invested capital (ROIC) is 2.97%.
| Return on Equity (ROE) | 2.52% |
| Return on Assets (ROA) | 2.66% |
| Return on Invested Capital (ROIC) | 2.97% |
| Return on Capital Employed (ROCE) | 5.00% |
| Revenue Per Employee | $503,871 |
| Profits Per Employee | $20,597 |
| Employee Count | 5,000 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.37 |
Taxes
In the past 12 months, Globus Medical has paid $17.74 million in taxes.
| Income Tax | 17.74M |
| Effective Tax Rate | 14.69% |
Stock Price Statistics
The stock price has increased by +48.23% in the last 52 weeks. The beta is 1.19, so Globus Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +48.23% |
| 50-Day Moving Average | 86.45 |
| 200-Day Moving Average | 75.19 |
| Relative Strength Index (RSI) | 25.41 |
| Average Volume (20 Days) | 1,259,642 |
Short Selling Information
The latest short interest is 2.18 million, so 1.60% of the outstanding shares have been sold short.
| Short Interest | 2.18M |
| Short Previous Month | 2.49M |
| Short % of Shares Out | 1.60% |
| Short % of Float | 1.93% |
| Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, Globus Medical had revenue of $2.52 billion and earned $102.98 million in profits. Earnings per share was $0.75.
| Revenue | 2.52B |
| Gross Profit | 1.48B |
| Operating Income | 219.70M |
| Pretax Income | 66.55M |
| Net Income | 102.98M |
| EBITDA | 473.73M |
| EBIT | 219.70M |
| Earnings Per Share (EPS) | $0.75 |
Full Income StatementBalance Sheet
The company has $890.06 million in cash and $537.19 million in debt, giving a net cash position of $419.00 million or $3.08 per share.
| Cash & Cash Equivalents | 890.06M |
| Total Debt | 537.19M |
| Net Cash | 419.00M |
| Net Cash Per Share | $3.08 |
| Equity (Book Value) | 4.18B |
| Book Value Per Share | 30.40 |
| Working Capital | 1.32B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $520.64 million and capital expenditures -$115.43 million, giving a free cash flow of $405.21 million.
| Operating Cash Flow | 520.64M |
| Capital Expenditures | -115.43M |
| Free Cash Flow | 405.21M |
| FCF Per Share | $2.98 |
Full Cash Flow StatementMargins
Gross margin is 58.90%, with operating and profit margins of 8.72% and 4.09%.
| Gross Margin | 58.90% |
| Operating Margin | 8.72% |
| Pretax Margin | 4.79% |
| Profit Margin | 4.09% |
| EBITDA Margin | 18.80% |
| EBIT Margin | 8.72% |
| FCF Margin | 16.08% |